An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Top results in this bookTable of Contents
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Common Syndromes in Older Adults Related to Primary and Secondary Prevention [Internet].
Kane RL, Talley KMC, Shamliyan T, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jul. (Evidence Syntheses/Technology Assessments, No. 87.)
Rivaroxaban (Xarelto): Treatment of Venous Thromboembolic Events (Deep Vein Thrombosis [DVT], Pulmonary Embolism [PE]) and Prevention of Recurrent DVT and PE [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JAC, Bodalia PN, Bryden PA, et al.
Southampton (UK): NIHR Journals Library; 2017 Mar. (Health Technology Assessment, No. 21.9.)
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Disease Control Priorities in Developing Countries. 2nd edition.
Jamison DT, Breman JG, Measham AR, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; New York: Oxford University Press; 2006.
Therapeutics Letter.
Perry T, editor.
Vancouver (BC): Therapeutic Initiatives; 1994-.
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R, McFadden E, McLellan J, et al.
Southampton (UK): NIHR Journals Library; 2015 Dec. (Health Technology Assessment, No. 19.100.)
Clinical Review Report: Rivaroxaban (Xarelto): Bayer Inc. Indication: In combination with 75 mg to 100 mg acetylsalicylic acid, for the prevention of stroke, myocardial infarction, and cardiovascular death, and for the prevention of acute limb ischemia and mortality in patients with coronary artery disease with or without peripheral artery disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan.
Cardiovascular, Respiratory, and Related Disorders. 3rd edition.
Prabhakaran D, Anand S, Gaziano TA, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England.
Judge A, Javaid MK, Leal J, et al.
Southampton (UK): NIHR Journals Library; 2016 Sep. (Health Services and Delivery Research, No. 4.28.)
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P, Connock M, Gurung T, et al.
Southampton (UK): NIHR Journals Library; 2013 Sep. (Health Technology Assessment, No. 17.43.)
Orthogeriatrics: The Management of Older Patients with Fragility Fractures [Internet]. 2nd edition.
Falaschi P, Marsh D, editors.
Cham (CH): Springer; 2021.
Pharmacoeconomic Review Report: Rivaroxaban (Xarelto): (Bayer Inc.): Indication: In combination with 75 mg to 100 mg acetylsalicylic acid (ASA), for the prevention of stroke, myocardial infarction, and cardiovascular death, and for the prevention of acute limb ischemia and mortality in patients with coronary artery disease (CAD) with or without peripheral artery disease (PAD) [Internet].
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL, Mendes D, Clegg AJ, et al.
Southampton (UK): NIHR Journals Library; 2014 Aug. (Health Technology Assessment, No. 18.56.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on